Literature DB >> 18269225

Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans.

Michie Kosuge1, Toshihide Takeuchi, Ikuhiko Nakase, Arwyn Tomos Jones, Shiroh Futaki.   

Abstract

The exact mechanisms by which arginine-rich cell-penetrating peptides enter cells are still the subject of debate. Here, we have analyzed in detail the effects of serum and extracellular concentration on the internalization of oligoarginines (R n; n = 4, 8, 12, 16). The presence of serum in the incubation medium had a major influence on the uptake of R12 and R16 peptides but did not affect the uptake of R4 and R8 significantly. Incubation of cells at 37 degrees C with R12 and R16 peptides in serum-containing medium showed that the majority of labeling was confined to punctate endocytic structures. Performing the same experiments in serum-free media led to a dramatic increase in cytosolic labeling, and similarly diffuse R12 and R16 labeling was observed in cells treated with peptides at 4 degrees C. This suggests, in both cases, that the peptides were entering via a nonendocytic mechanism. Further studies on R12 peptide suggest that the initiation of nonendocytic uptake and cytosolic labeling is also dependent on serum concentration and extracellular peptide concentration. At relatively low concentrations, the peptide labels endocytic structures, but upon raising the peptide concentration, the fraction labeling the cytosol increases dramatically and this accompanies a nonlinear increase in total cellular fluorescence. Membrane-associated proteoglycans also contribute to increasing the peptide concentration at the cell surface by enhancing their recruitment via electrostatic interactions. These results demonstrate that uptake mechanisms of these compounds are highly dependent on both the presence of serum and the effective extracellular peptide concentration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18269225     DOI: 10.1021/bc700289w

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  68 in total

1.  Co-operative membrane disruption between cell-penetrating peptide and cargo: implications for the therapeutic use of the Bcl-2 converter peptide D-NuBCP-9-r8.

Authors:  Catherine L Watkins; Edward J Sayers; Chris Allender; David Barrow; Christopher Fegan; Paul Brennan; Arwyn T Jones
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

2.  Do cell-penetrating peptides actually "penetrate" cellular membranes?

Authors:  Caroline Palm-Apergi; Peter Lönn; Steven F Dowdy
Journal:  Mol Ther       Date:  2012-04       Impact factor: 11.454

Review 3.  Targeting antibodies to the cytoplasm.

Authors:  Andrea L J Marschall; André Frenzel; Thomas Schirrmann; Manuela Schüngel; Stefan Dübel
Journal:  MAbs       Date:  2011-01-01       Impact factor: 5.857

4.  Membrane Oxidation Enables the Cytosolic Entry of Polyarginine Cell-penetrating Peptides.

Authors:  Ting-Yi Wang; Yusha Sun; Nandhini Muthukrishnan; Alfredo Erazo-Oliveras; Kristina Najjar; Jean-Philippe Pellois
Journal:  J Biol Chem       Date:  2016-02-17       Impact factor: 5.157

5.  A peptide for transcellular cargo delivery: Structure-function relationship and mechanism of action.

Authors:  Alexander Komin; Maxim I Bogorad; Ran Lin; Honggang Cui; Peter C Searson; Kalina Hristova
Journal:  J Control Release       Date:  2020-05-28       Impact factor: 9.776

6.  A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency.

Authors:  Falk Duchardt; Ivo R Ruttekolk; Wouter P R Verdurmen; Hugues Lortat-Jacob; Jochen Bürck; Hansjörg Hufnagel; Rainer Fischer; Maaike van den Heuvel; Dennis W P M Löwik; Geerten W Vuister; Anne Ulrich; Michel de Waard; Roland Brock
Journal:  J Biol Chem       Date:  2009-10-26       Impact factor: 5.157

7.  An amino acid-based amphoteric liposomal delivery system for systemic administration of siRNA.

Authors:  Roger C Adami; Shaguna Seth; Pierrot Harvie; Rachel Johns; Renata Fam; Kathy Fosnaugh; Tianying Zhu; Ken Farber; Michael McCutcheon; Thomas T Goodman; Yan Liu; Yan Chen; Erin Kwang; Michael V Templin; Greg Severson; Tod Brown; Narendra Vaish; Feng Chen; Patrick Charmley; Barry Polisky; Michael E Houston
Journal:  Mol Ther       Date:  2011-04-19       Impact factor: 11.454

8.  A critical assessment of the synthesis and biological activity of p53/human double minute 2-stapled peptide inhibitors.

Authors:  Rike Wallbrecher; Patrick Chène; Stephan Ruetz; Therese Stachyra; Thomas Vorherr; Roland Brock
Journal:  Br J Pharmacol       Date:  2017-07-06       Impact factor: 8.739

9.  Cell-penetrating peptides as delivery vehicles for a protein-targeted terbium complex.

Authors:  Shabnam Mohandessi; Megha Rajendran; Darren Magda; Lawrence W Miller
Journal:  Chemistry       Date:  2012-07-17       Impact factor: 5.236

10.  The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis.

Authors:  Nadia Rucci; Anna Rufo; Marina Alamanou; Mattia Capulli; Andrea Del Fattore; Emma Ahrman; Daria Capece; Valeria Iansante; Francesca Zazzeroni; Edoardo Alesse; Dick Heinegård; Anna Teti
Journal:  J Cell Biol       Date:  2009-11-30       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.